In acute toxicity studies with mice and rabbits, a dose of 20 ?g/kg of synthetic human secretin was not lethal with no clinical symptoms of toxicity. The no-observed-effect level (NOEL) in rats was 10 ?g/kg/day in a 14-day intravenous toxicity study without any evidence of adverse toxicity. The NOEL was 5 ?g/kg/day in dogs L1875.
Studies assessing the carcinogenic potential, mutagenicity, or potential for impairment of fertility have not been conducted with synthetic human secretin FDA Label.
Human secretin is a gastrointestinal peptide hormone that regulates secretions in the stomach, pancreas, and liver. The hormone is produced from the enterochromaffin cells in the duodenum in response to the duodenal content with the pH less than 4.5 L1875. The main action of secretin is to stimulate the pancreas to secrete pancreatic juice for pH regulation in the small intestines. Secretin is also responsible in body fluid homeostasis A32276 and bile production. Although it is a gastrointestinal hormone, secretin is also considered as a neuropeptide hormone since it is also expressed in the central nervous system A32275.
Purified synthetic human secretin, also referred to as RG1068, is available as an intravenous injection under the market name ChiRhoStim ® in the U.S.. It contains an amino acid sequence identical to the naturally occurring hormone consisting of 27 amino acids FDA Label that supports ?-helical formation A32275. The carboxyl-terminal amino acid, valine, is amidated. Synthetic human secretin displays equivalent biological activity and properties as naturally-occurring secretin A32265. It is indicated for the stimulation of the pancreatic and gastric secretions to aid in the diagnosis of pancreatic exocrine dysfunction and the diagnosis of gastrinoma, and facilitate the identification of the ampulla of Vater and accessory papilla during endoscopic retrograde cholangiopancreatography (ERCP).
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Tramadol | The therapeutic efficacy of Secretin human can be decreased when used in combination with Tramadol. |
| Trospium | The therapeutic efficacy of Secretin human can be decreased when used in combination with Trospium. |
| Oxyphenonium | The therapeutic efficacy of Secretin human can be decreased when used in combination with Oxyphenonium. |
| Butabarbital | The therapeutic efficacy of Secretin human can be decreased when used in combination with Butabarbital. |
| Butalbital | The therapeutic efficacy of Secretin human can be decreased when used in combination with Butalbital. |
| Benzatropine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Benzatropine. |
| Ziprasidone | The therapeutic efficacy of Secretin human can be decreased when used in combination with Ziprasidone. |
| Disopyramide | The therapeutic efficacy of Secretin human can be decreased when used in combination with Disopyramide. |
| Talbutal | The therapeutic efficacy of Secretin human can be decreased when used in combination with Talbutal. |
| Pentobarbital | The therapeutic efficacy of Secretin human can be decreased when used in combination with Pentobarbital. |
| Amitriptyline | The therapeutic efficacy of Secretin human can be decreased when used in combination with Amitriptyline. |
| Ipratropium | The therapeutic efficacy of Secretin human can be decreased when used in combination with Ipratropium. |
| Methadone | The therapeutic efficacy of Secretin human can be decreased when used in combination with Methadone. |
| Olanzapine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Olanzapine. |
| Metixene | The therapeutic efficacy of Secretin human can be decreased when used in combination with Metixene. |
| Terfenadine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Terfenadine. |
| Buclizine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Buclizine. |
| Clozapine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Clozapine. |
| Doxylamine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Doxylamine. |
| Trihexyphenidyl | The therapeutic efficacy of Secretin human can be decreased when used in combination with Trihexyphenidyl. |
| Oxyphencyclimine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Oxyphencyclimine. |
| Procyclidine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Procyclidine. |
| Profenamine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Profenamine. |
| Metocurine iodide | The therapeutic efficacy of Secretin human can be decreased when used in combination with Metocurine iodide. |
| Secobarbital | The therapeutic efficacy of Secretin human can be decreased when used in combination with Secobarbital. |
| Promazine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Promazine. |
| Hyoscyamine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Hyoscyamine. |
| Cyproheptadine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Cyproheptadine. |
| Imipramine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Imipramine. |
| Methscopolamine bromide | The therapeutic efficacy of Secretin human can be decreased when used in combination with Methscopolamine bromide. |
| Metharbital | The therapeutic efficacy of Secretin human can be decreased when used in combination with Metharbital. |
| Fluoxetine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Fluoxetine. |
| Chlorpromazine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Chlorpromazine. |
| Gallamine triethiodide | The therapeutic efficacy of Secretin human can be decreased when used in combination with Gallamine triethiodide. |
| Darifenacin | The therapeutic efficacy of Secretin human can be decreased when used in combination with Darifenacin. |
| Tridihexethyl | The therapeutic efficacy of Secretin human can be decreased when used in combination with Tridihexethyl. |
| Triflupromazine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Triflupromazine. |
| Dextromethorphan | The therapeutic efficacy of Secretin human can be decreased when used in combination with Dextromethorphan. |
| Anisotropine methylbromide | The therapeutic efficacy of Secretin human can be decreased when used in combination with Anisotropine methylbromide. |
| Nortriptyline | The therapeutic efficacy of Secretin human can be decreased when used in combination with Nortriptyline. |
| Amoxapine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Amoxapine. |
| Cisatracurium | The therapeutic efficacy of Secretin human can be decreased when used in combination with Cisatracurium. |
| Atropine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Atropine. |
| Thiopental | The therapeutic efficacy of Secretin human can be decreased when used in combination with Thiopental. |
| Nicardipine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Nicardipine. |
| Mecamylamine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Mecamylamine. |
| Pirenzepine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Pirenzepine. |
| Paroxetine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Paroxetine. |
| Procaine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Procaine. |
| Homatropine methylbromide | The therapeutic efficacy of Secretin human can be decreased when used in combination with Homatropine methylbromide. |
| Rocuronium | The therapeutic efficacy of Secretin human can be decreased when used in combination with Rocuronium. |
| Atracurium besylate | The therapeutic efficacy of Secretin human can be decreased when used in combination with Atracurium besylate. |
| Scopolamine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Scopolamine. |
| Isoflurane | The therapeutic efficacy of Secretin human can be decreased when used in combination with Isoflurane. |
| Benzquinamide | The therapeutic efficacy of Secretin human can be decreased when used in combination with Benzquinamide. |
| Clidinium | The therapeutic efficacy of Secretin human can be decreased when used in combination with Clidinium. |
| Propiomazine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Propiomazine. |
| Propantheline | The therapeutic efficacy of Secretin human can be decreased when used in combination with Propantheline. |
| Primidone | The therapeutic efficacy of Secretin human can be decreased when used in combination with Primidone. |
| Dicyclomine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Dicyclomine. |
| Biperiden | The therapeutic efficacy of Secretin human can be decreased when used in combination with Biperiden. |
| Brompheniramine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Brompheniramine. |
| Methylphenobarbital | The therapeutic efficacy of Secretin human can be decreased when used in combination with Methylphenobarbital. |
| Cocaine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Cocaine. |
| Quinidine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Quinidine. |
| Amantadine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Amantadine. |
| Maprotiline | The therapeutic efficacy of Secretin human can be decreased when used in combination with Maprotiline. |
| Methantheline | The therapeutic efficacy of Secretin human can be decreased when used in combination with Methantheline. |
| Hexafluronium | The therapeutic efficacy of Secretin human can be decreased when used in combination with Hexafluronium. |
| Cycrimine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Cycrimine. |
| Desloratadine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Desloratadine. |
| Glycopyrronium | The therapeutic efficacy of Secretin human can be decreased when used in combination with Glycopyrronium. |
| Tolterodine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Tolterodine. |
| Oxybutynin | The therapeutic efficacy of Secretin human can be decreased when used in combination with Oxybutynin. |
| Promethazine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Promethazine. |
| Diphenhydramine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Diphenhydramine. |
| Pentolinium | The therapeutic efficacy of Secretin human can be decreased when used in combination with Pentolinium. |
| Trimethaphan | The therapeutic efficacy of Secretin human can be decreased when used in combination with Trimethaphan. |
| Doxacurium | The therapeutic efficacy of Secretin human can be decreased when used in combination with Doxacurium. |
| Doxepin | The therapeutic efficacy of Secretin human can be decreased when used in combination with Doxepin. |
| Flavoxate | The therapeutic efficacy of Secretin human can be decreased when used in combination with Flavoxate. |
| Desipramine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Desipramine. |
| Orphenadrine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Orphenadrine. |
| Phenobarbital | The therapeutic efficacy of Secretin human can be decreased when used in combination with Phenobarbital. |
| Escitalopram | The therapeutic efficacy of Secretin human can be decreased when used in combination with Escitalopram. |
| Tubocurarine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Tubocurarine. |
| Quetiapine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Quetiapine. |
| Mivacurium | The therapeutic efficacy of Secretin human can be decreased when used in combination with Mivacurium. |
| Levacetylmethadol | The therapeutic efficacy of Secretin human can be decreased when used in combination with Levacetylmethadol. |
| Diphenidol | The therapeutic efficacy of Secretin human can be decreased when used in combination with Diphenidol. |
| Aripiprazole | The therapeutic efficacy of Secretin human can be decreased when used in combination with Aripiprazole. |
| Chlorprothixene | The therapeutic efficacy of Secretin human can be decreased when used in combination with Chlorprothixene. |
| Fenoterol | The therapeutic efficacy of Secretin human can be decreased when used in combination with Fenoterol. |
| Metocurine | The therapeutic efficacy of Secretin human can be decreased when used in combination with Metocurine. |
| Pancuronium | The therapeutic efficacy of Secretin human can be decreased when used in combination with Pancuronium. |
| Pipecuronium | The therapeutic efficacy of Secretin human can be decreased when used in combination with Pipecuronium. |
| Vecuronium | The therapeutic efficacy of Secretin human can be decreased when used in combination with Vecuronium. |
| Amobarbital | The therapeutic efficacy of Secretin human can be decreased when used in combination with Amobarbital. |
| Aprobarbital | The therapeutic efficacy of Secretin human can be decreased when used in combination with Aprobarbital. |
| Butobarbital | The therapeutic efficacy of Secretin human can be decreased when used in combination with Butobarbital. |